NCT01028950View on ClinicalTrials.gov

YM150 for Prevention of Venous Thromboembolism in Patients With Acute Medical Illness

PHASE3CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Venous Thromboembolism
Interventions
DRUG

YM150

oral

Trial Locations (5)

Unknown

Chugoku

Chūbu

Kansai

Kantou

Tōhoku

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT01028950 - YM150 for Prevention of Venous Thromboembolism in Patients With Acute Medical Illness | Biotech Hunter | Biotech Hunter